Virax Biolabs News - VRAX

Company Name	Stock Ticker Symbol	Market	Type
Virax Biolabs Group Ltd	VRAX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0103	1.52%	0.69	09:30:03

Open Price	Low Price	High Price	Close Price	Prev Close
0.69	0.69	0.69		0.6797

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	07:30	PRNUS	Virax Biolabs to Participate at ESCMID Global 2024
3/15/2024	16:30	PRNUS	Virax Biolabs Announces Receipt of NASDAQ Notification..
1/22/2024	17:28	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/22/2024	17:27	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/12/2024	07:43	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/2023	07:34	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/2023	07:30	PRNUS	Virax Biolabs Forges Strategic Research Collaboration with..
12/20/2023	16:12	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
12/20/2023	16:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/2023	16:03	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
12/18/2023	07:37	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/18/2023	07:30	PRNUS	Virax Biolabs' CEO James Foster Issues Letter to..
12/18/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/14/2023	07:43	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/2023	07:30	PRNUS	Virax Biolabs Group Limited Announces 1-for-10 Share..
12/08/2023	06:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/05/2023	16:06	EDGAR2	Form F-3 - Registration statement by foreign private issuers
11/08/2023	16:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/2023	16:38	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/2023	08:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/2023	07:24	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/2023	07:49	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/2023	07:30	PRNUS	Virax Biolabs Group Announces Early-Access Program Launch of..
9/01/2023	07:37	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/2023	07:30	PRNUS	Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief..
8/03/2023	08:39	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/03/2023	07:30	PRNUS	Nasdaq Approves 180-Day Extension for Virax Biolabs Group to..
7/18/2023	07:58	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/18/2023	07:30	PRNUS	Virax Biolabs Group Continues Growth and Expansion with the..
6/14/2023	07:30	PRNUS	Virax Biolabs' CEO James Foster Issues Letter to..
5/04/2023	07:30	PRNUS	Virax Biolabs Group Announces Establishment of Regional..